Learned cervical-cancer recurrence models show modest internal discrimination
Source check: Source checked. Not independent scientific confirmation.
Finding: In a retrospective four-hospital cervical-cancer analysis, learned models estimated recurrence and survival using recorded clinical and pathological factors. The 1,023-person test set was a random split of the same hospital pool. Site-specific recurrence discrimination was modest, and external clinical benefit was not established.
Technology: Support vector machine and tree-based survival/classification models
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned classifiers and representations evaluate a defined clinical staging or recurrence target; conventional clinicopathologic associations are not separately counted as AI discoveries.
- Test and result
- The source analyzed 5,112 surgically treated patients, 268 deaths and 343 recurrences, with an 80:20 stratified split, training-only ADASYN and five-fold grid search. For all 22 variables, test recurrence AUC was .794 for SVM versus .785 for logistic regression; site-specific recurrence AUC was .781 versus .776. SVM local/distant test sensitivities were .472/.424 at the represented operating points.
- Limitation / still unknown
- The source calls the test external, but Methods randomly divide patients pooled from the same four hospitals; this is internal evaluation. Some feature subsets are selected from whole-cohort Cox associations, and containment is not established. Inputs include postoperative pathology/adjuvant treatment, so this is not preoperative prediction or a causal treatment-effect model. Recurrence event counts differ 343 versus 344 across source locations. Binary risk endpoints do not supply a frozen future prediction horizon. Source claims of a universally best model are not supported across all displayed table cells; no clinical surveillance benefit is measured.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7907920/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 21 Nov 2026. Review scope: Original patient cohort, computational Methods and represented Results actually read.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.